Vaccine-Associated Paralytic Poliomyelitis: A case report

سال انتشار: 1400
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 97

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

IHSC14_464

تاریخ نمایه سازی: 19 شهریور 1401

چکیده مقاله:

Introduction: For as long as IRAN uses Oral polio vaccine (OPV; Containing live attenuated viruses), for expanded program on childhood immunization. The most severe complication caused by OPV is Vaccine-associated paralytic (VAPP). VAPP is more common in people with Immunodeficiency.Patient Report: The case is an Iranian infant, born on February ۲۱, ۲۰۱۸ and birth weight ۲۲۰۰gr., with cellular immune deficiency. Date of onset of paralysis is ۹۷ days after receiving the second dose of OPV at the age of ۷ months on October ۲, ۲۰۱۸. Paralysis of the respiratory muscles occurred with tachypnea and fever. According to the world protocol, two stool samples were taken from the patient. The results of both samples with both L۲۰B & RD cell line tests were Positive and vaccine-derived polio virus isolated from the patient's stool. The examinations done by the national referral laboratory of the Tehran University of medical sciences.Conclusion: A decrease in the Percent of children immunization coverage conduces to circulating Vaccine-Derived Polio Virus (cVDPV) as well as, viral excretion by people withimmune deficiency in the community. In addition to cause a poliomyelitis infection in these people, it can endangers the global polio eradication Initiative (GPEI).

نویسندگان

Sadegh Kargarian-Marvasti

MSc of Epidemiology, General MPH, Isfahan University of Medical Sciences, Isfahan, Iran

Esmaeil Akhtar

BSc of Public Health, Isfahan University of Medical Sciences, Manager of vaccine-preventable diseases, Isfahan Health Center, Isfahan, Iran

Reza Fadayi

Infectious diseases Specialist, Assistant professor, Faculty member of Isfahan University of Medical Sciences, Isfahan, Iran

Sima Afrashteh

PhD Candidate in Epidemiology, Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran

Afshin Moliani

M.D., Manager of Fereydunshahr Health Care Center, Isfahan University of Medical Sciences, Isfahan, Iran